This inventor holds 3 USPTO granted patents and 4 published patent applications. Top assignees: Gt Medical Technologies, Inc., Mim Software, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Adam Turner - Innovator in Radiation Therapy
Introduction
Adam Turner is a notable inventor based in Phoenix, AZ, who has made significant contributions to the field of radiation therapy. With a total of 3 patents, he has developed innovative solutions that enhance treatment planning and safety in medical applications.
Latest Patents
Turner's latest patents include a "Base Dose Calculation" tool, which is designed to determine a base dose employed in treatment planning. This tool considers base therapy information on a voxelized and temporal basis, allowing for the planning of subsequent treatments. The output from this base dose calculation is compatible with existing treatment planning systems. Another significant patent is for a "Radiation Shielding Apparatus for Implantable Radioactive Seeds." This invention focuses on devices used in radiation therapy, discussing various configurations of shielding materials within layers to protect against radiation from radioactive sources within implanted carriers.
Career Highlights
Adam Turner is currently associated with GT Medical Technologies, Inc., where he applies his expertise in developing advanced medical technologies. His work is pivotal in improving patient outcomes in radiation therapy.
Collaborations
Turner collaborates with talented professionals in his field, including David Brachman and John Baker, who contribute to the innovative environment at GT Medical Technologies, Inc.
Conclusion
Adam Turner's contributions to radiation therapy through his patents and collaborations highlight his commitment to advancing medical technology. His work continues to impact the field positively, ensuring safer and more effective treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

